Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.2797
Abstract: PD(L)1 antibodies (anti‐PD(L)‐1) have been a major breakthrough in several types of cancer. Novel patterns of response and progression have been described with anti‐PD(L)‐1. We aimed at characterizing pseudoprogression (PSPD) among patients with various solid… read more here.
Keywords: tumor types; patients treated; evidence pseudoprogression; pseudoprogression ... See more keywords